About Cochlear Limited (COH)
Cochlear Limited is a Medical Devices company operating in the Healthcare sector.
COH trades on the Australian Securities Exchange and is classified as a large-cap stock .
Key Statistics
- Current Price
- A$143.64
- Market Cap
- A$9.39B
- 52-Week High
- A$291.20
- 52-Week Low
- A$88.74
- Sector
- Healthcare
- Industry
- Medical Devices
A$1,000 Invested in Cochlear Limited (COH)
How much would A$1,000 invested in COH be worth today?
What would A$1,000 invested in COH 1 year ago be worth today?
A A$1,000 investment in Cochlear Limited (COH) in 2025 would be worth A$511 as of November 2026, representing a -48.9% total return.
What would A$1,000 invested in COH 3 years ago be worth today?
A A$1,000 investment in Cochlear Limited (COH) in 2023 would be worth A$628 as of November 2026, representing a -37.3% total return.
What would A$1,000 invested in COH 5 years ago be worth today?
A A$1,000 investment in Cochlear Limited (COH) in 2021 would be worth A$705 as of November 2026, representing a -29.5% total return.
What would A$1,000 invested in COH 10 years ago be worth today?
A A$1,000 investment in Cochlear Limited (COH) in 2016 would be worth A$1,292 as of November 2026, representing a +29.2% total return.
What would A$1,000 invested in COH at IPO be worth today?
A A$1,000 investment in Cochlear Limited (COH) at IPO would be worth A$98,541 as of November 2026, representing a +9754.1% total return.
Monthly Returns Heatmap
Over the past 30+ years (370 months), Cochlear Limited (COH) has averaged a monthly return of +1.62% with a median return of +1.88%. The stock had 224 positive months (61%) and 145 negative months (39%). The best month in COH's history was August 2008 with a +26.4% return, while the worst was April 2026 at -44.4%. Historically, August tends to be the strongest month (averaging +4.0%), and September the weakest (0.0%).
COH's longest winning streak was 9 consecutive months of gains, while its longest losing streak was 7 consecutive months of losses. The best full year was 1999 with a cumulative return of +86.7%, and the worst was 2003 at -51.9%.
Annual Returns
Over 31 years of trading history, Cochlear Limited (COH) has delivered an average annual return of +21.92% with a median return of +25.95%. The compound annual growth rate (CAGR) is +15.95%. The stock posted gains in 21 years (68%) and losses in 10 years (32%).
COH's best year was 1999 with a +123.56% gain, while the worst was 2003 at -43.65%. The longest streak of consecutive positive years was 6, and the longest losing streak was 3 years. COH achieved double-digit gains (10%+) in 20 years. It suffered double-digit losses in 7 years.
| Year | Return | Start | End |
|---|---|---|---|
| 2026 | -43.65% | A$254.91 | A$143.64 |
| 2025 | -8.69% | A$279.18 | A$254.91 |
| 2024 | -1.64% | A$283.83 | A$279.18 |
| 2023 | +48.33% | A$191.36 | A$283.83 |
| 2022 | -4.22% | A$199.79 | A$191.36 |
| 2021 | +15.66% | A$172.74 | A$199.79 |
| 2020 | -15.90% | A$205.40 | A$172.74 |
| 2019 | +31.71% | A$155.95 | A$205.40 |
| 2018 | +2.91% | A$151.54 | A$155.95 |
| 2017 | +42.35% | A$106.45 | A$151.54 |
| 2016 | +30.72% | A$81.44 | A$106.45 |
| 2015 | +25.76% | A$64.76 | A$81.44 |
| 2014 | +37.21% | A$47.19 | A$64.76 |
| 2013 | -22.50% | A$60.90 | A$47.19 |
| 2012 | +32.48% | A$45.97 | A$60.90 |
| 2011 | -20.57% | A$57.87 | A$45.97 |
| 2010 | +20.01% | A$48.22 | A$57.87 |
| 2009 | +28.55% | A$37.51 | A$48.22 |
| 2008 | -23.94% | A$49.32 | A$37.51 |
| 2007 | +31.72% | A$37.44 | A$49.32 |
| 2006 | +29.49% | A$28.92 | A$37.44 |
| 2005 | +85.26% | A$15.61 | A$28.92 |
| 2004 | +22.38% | A$12.75 | A$15.61 |
| 2003 | -43.65% | A$22.63 | A$12.75 |
| 2002 | -13.21% | A$26.08 | A$22.63 |
| 2001 | +25.95% | A$20.70 | A$26.08 |
| 2000 | +82.27% | A$11.36 | A$20.70 |
| 1999 | +123.56% | A$5.08 | A$11.36 |
| 1998 | +88.60% | A$2.69 | A$5.08 |
| 1997 | +45.20% | A$1.86 | A$2.69 |
| 1996 | +27.23% | A$1.46 | A$1.86 |
Frequently Asked Questions: COH
What sector is COH in? ▼
COH operates in the Healthcare sector, specifically in the Medical Devices industry. This sector includes pharmaceutical companies, biotechnology firms, medical device manufacturers, and healthcare providers.
How has COH performed historically? ▼
Over 31 years of trading history, COH has posted gains in 21 years (68% of the time). The best year was 1999 with a +123.6% return. Past performance does not guarantee future results.
How can I invest in COH? ▼
You can invest in COH through any brokerage account that offers access to the Australian Securities Exchange. Popular options include commission-free brokers like Fidelity, Charles Schwab, or Robinhood (US), or international brokers like Interactive Brokers. You can buy individual shares or invest through ETFs that hold COH.
Last updated: 11/1/2026